icon-folder.gif   Conference Reports for NATAP  
 
  53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO
Back grey_arrow_rt.gif
 
 
 
Switch from efavirenz/emtricitabine/tenofovir DF to elvitegravir/cobicistat/emtricitabine/tenofovir DF: Efficacy and Pharmacokinetics
 
 
  Reported by Jules Levin
ICAAC 2013 Denver Colorado Sept 10-13
 
C Cohen1, R Elion2, P Ruane3, D Shamblaw4, E DeJesus5, B Rashbaum6, J Custodio7, S Ramanathan7, M Fordyce7, MS Rhee7, B Kearney7, J Szwarcberg7 1Community Research Initiative, Boston, MA, US; 2Whitman Walker Clinic, Washington, DC, US; 3Peter J. Ruane, MD, Inc., Los Angeles, CA, US; 4La Playa Medical Group and Clinical Research, San Diego, CA, US; 5Orlando Immunology Center, Orlando, FL, US; 6Capital Medical Associates PC, Washington, DC, US; 7Gilead Sciences, Foster City, CA, US

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif